NCT01388530View on ClinicalTrials.gov

Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
DEVICE

EMS 7500 Digital Muscle Stimulator

A standard FDA approved transcutaneous electrical nerve stimulation (TENS) unit will be used to apply low intensity stimulation to the trigeminal nerves during sleep.

Trial Locations (1)

90095

UCLA, Los Angeles

Sponsors

Collaborators (1)

NeuroSigma, Inc.
All Listed Sponsors
collaborator

NeuroSigma, Inc.

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT01388530 - Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter